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Abstract
Heterozygous mutations of the Hfe gene have been proposed as cofactors in
the development and progression of nonalcoholic fatty liver disease (NAFLD).
Homozygous Hfe deletion previously has been shown to lead to dysregulated
hepatic lipid metabolism and accentuated liver injury in a dietary mouse
model of NAFLD. We sought to establish whether heterozygous deletion of
Hfe is sufficient to promote liver injury when mice are exposed to a high-cal-
orie diet (HCD). Eight-week-old wild-type and Hfe+/ mice received 8 weeks
of a control diet or HCD. Liver histology and pathways of lipid and iron
metabolism were analyzed. Liver histology demonstrated that mice fed a HCD
had increased NAFLD activity score (NAS), steatosis, and hepatocyte balloon-
ing. However, liver injury was unaffected by Hfe genotype. Hepatic iron con-
centration (HIC) was increased in Hfe+/ mice of both dietary groups. HCD
resulted in a hepcidin-independent reduction in HIC. Hfe+/ mice demon-
strated raised fasting serum glucose concentrations and HOMA-IR score,
despite unaltered serum adiponectin concentrations. Downstream regulators
of hepatic de novo lipogenesis (pAKT, SREBP-1, Fas, Scd1) and fatty acid oxi-
dation (AdipoR2, Ppara, Cpt1) were largely unaffected by genotype. In sum-
mary, heterozygous Hfe gene deletion is associated with impaired iron and
glucose metabolism. However, unlike homozygous Hfe deletion, heterozygous
gene deletion did not affect lipid metabolism pathways or liver injury in this
model.
Introduction
Nonalcoholic fatty liver disease (NAFLD) is increasingly
common in the developed and developing world, affecting
around 30% of many adult populations (Amarapurkar
et al. 2007; Vernon et al. 2011). The advanced form of
the disease, nonalcoholic steatohepatitis (NASH), can lead
to life-threatening complications including liver failure
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and liver cancer (Anstee et al. 2013). At present, effective
treatment strategies to halt or reverse the natural history
of NASH are lacking. Cofactors such as type II diabetes
mellitus and iron overload have been implicated in NASH
pathogenesis and represent readily treatable therapeutic
targets (Dongiovanni et al. 2011; Smith and Adams
2011). A greater understanding of the mechanisms by
which such cofactors promote NASH disease progression
is essential in order to develop effective treatments.
Iron overload due to homozygous p.C282Y mutation
of Hfe is responsible for the majority of cases of heredi-
tary hemochromatosis seen worldwide (Bacon et al.
2011). Heterozygous p.C282Y mutations are found in
approximately 11% of Caucasian populations and are
associated with increased iron stores, but not with liver
disease in the absence of an additional cofactor (Allen
et al. 2008). In a large meta-analysis, Hfe gene mutations
have been shown to convey an increased risk of nonalco-
holic steatohepatitis (Ellervik et al. 2007). Among individ-
uals with NAFLD, the presence of the heterozygous
p.H63D mutation of Hfe has been shown to be associated
with more advanced histological injury as assessed by the
NAFLD activity score (Nelson et al. 2012). An overview
of the role of HFE in mammalian iron metabolism is
summarized in Figure 1.
Liver injury in both hemochromatosis and NASH is
characterized by the presence of oxidative stress (Bacon
et al. 2011; Rolo et al. 2012). Insulin resistance, itself
associated with oxidative stress, is commonly observed
both in individuals with NASH and also in those with
hemochromatosis (Smith and Adams 2011; Simcox and
McClain 2013). Given the prevalence of Hfe gene muta-
tions and shared pathogenic mechanisms with NASH,
they have received intense interest in recent years as
potential cofactors in NAFLD disease progression.
Previous work from our group has demonstrated that
mice with homozygous Hfe deletion which are fed a high-
calorie diet (HCD) develop steatohepatitis and early
fibrosis (Tan et al. 2011). This effect of diet is not seen in
wild-type controls which develop only simple steatosis. In
this model, Hfe null mice demonstrated upregulation of
gene expression of de novo lipogenesis pathways and
downregulation of fatty acid oxidation pathways. This
imbalance of fatty acid synthesis and oxidation may
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Figure 1. Overview of the regulation of mammalian iron homeostasis. The regulation of mammalian iron homeostasis is predominantly
achieved via the control of duodenal absorption of iron by the hormone hepcidin. Hepcidin causes the internalization and degradation of the
iron-exporter ferroportin, thus reducing the passage of iron from enterocytes into the circulation. Other key proteins involved in duodenal iron
absorption, divalent metal transporter 1 (DMT-1), and the two oxidoreductases, hephaestin (Heph) and duodenal cytochrome B (DcytB), are
shown. The HAMP gene encodes hepcidin and is regulated by a number of factors including iron, via the HFE and bone morphogenetic protein
6 (BMP-6) pathway, hypoxia, via the BMP-6 pathway, and inflammation, via an interleukin-6 receptor (IL-6) pathway. R denotes receptor.
Adapted from Fleming et al. (Fleming and Ponka 2012) and Chua et al. (Chua et al. 2007).
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explain the liver injury seen in these Hfe null mice. How-
ever, the mechanisms by which Hfe deletion might dys-
regulate hepatic lipid metabolism remain to be defined.
These findings led us to consider whether a partial defi-
ciency of functional HFE, as seen in those with heterozy-
gous C282Y and H63D mutations, might be sufficient to
dysregulate hepatic lipid metabolism and promote liver
injury in NAFLD. In this article, we sought to explore the
mechanisms of interaction between heterozygous Hfe gene
mutations and nonalcoholic fatty liver disease. We
hypothesized that heterozygous Hfe deletion promotes
dysregulated hepatic lipid metabolism as seen in the
homozygous model. To test this hypothesis, we applied
the 8-week high-calorie diet model of NAFLD, previously
used in Hfe homozygous null mice, to mice with and
without heterozygous deletion of Hfe.
Materials and Methods
Experimental animals
Eight-week-old male C57BL6/J Hfe+/ mice (bred at the
QIMR Berghofer Medical Research Institute, Brisbane,
Australia) and wild-type (WT) littermate controls were
assigned to receive a control diet (CD) or a high-calorie
(40.5% sucrose, 23.5% fat, 0.19% cholesterol by weight)
diet (HCD) for 8 weeks (n = 10 per group). The con-
stituents of these diets are summarized in Table 1. Both
diets contained 1.3 lmol/g iron. The high-calorie diet is
analogous to a “Western” style diet, containing a high
content of fat, simple carbohydrates, and cholesterol (Tan
et al. 2011). Both diets were supplied by Specialty Feeds,
Glen Forrest, Western Australia. All animals were cared
for in accordance with the NHMRC code for the care
and use of animals for scientific purposes and with
approval of the Animal Ethics Committee of the QIMR
Berghofer Medical Research Institute. Mice were housed
in a temperature controlled environment (23°C) with a
12:12-h light:dark cycle. Mice had ad libitum access to
diet and water.
Sixteen-week-old mice were sacrificed by general anes-
thesia with intraperitoneal injection of ketamine and xyla-
zine, following a 5-h fast. Blood was collected by cardiac
puncture and serum was stored at 80°C. Livers were
excised, and pieces of tissue were either dried at 100°C
for 72 h for hepatic iron concentration determination,
fixed in formalin for histology, or snap frozen in liquid
nitrogen and stored at 80°C. Small bowel enterocytes
were collected as described previously (Chen et al. 2003;
Fuqua et al. 2014). In brief, 10-cm sections of proximal
small bowel were cut longitudinally then washed in ice-
cold phosphate-buffered saline (PBS). Samples were then
gently rotated for 30 min at 4°C in 1.5 mmol/L ethylene-
diaminetetraacetic acid (EDTA) in PBS. The gut tissue
was removed and the remaining sample containing ente-
rocytes was centrifuged at 500 g to pellet the enterocytes.
Histological assessment
Formalin-fixed samples were embedded in paraffin. Sec-
tions were stained with hematoxylin and eosin (H&E) for
the assessment of liver injury. Sirius red staining was used
to detect the presence of hepatic fibrosis. Histological
scoring was performed by an expert histopathologist
blinded to the study groups according to criteria
described by Kleiner et al. (Kleiner et al. 2005).
Hepatic iron concentration
Oven dried liver samples weighing 4–9 mg were added to
300 lL of concentrated nitric acid. Duplicate samples for
each liver were then digested in a heated sand bath. Chro-
mogen reagent was prepared (0.1% banthophenanthroline
sulfate, 1% mercaptoacetic acid). One part of chromogen
reagent was added to five parts of saturated sodium acet-
ate to make working chromogen reagent immediately
prior to use. When fully digested, the volume of each
sample was determined by pipette and 25 lL was added
to 125 lL working chromogen reagent. Absorbance was
measured at 540 nm on a plate reader, Tecan infinite
F200, Tecan, Switzerland. The iron concentration by dry
weight was determined with reference to an iron standard
(Iron standard for AAS, Sigma, St. Louis).
Serum analysis
Serum alanine aminotransferase (ALT) was measured on
a Beckman (DxC800) General Chemistry Automated
Table 1. Major components of experimental diets.
Dietary component Control diet High-calorie diet
Protein (% weight) 19.4% 19.4%
Total fat (% weight) 7.0% 23.0%
Total carbohydrate (% weight) 61.7% 50%
Digestible energy (MJ/kg) 16.1 20
Cholesterol (% weight) 0% 0.19%
Casein (acid) (g/kg) 200 200
Sucrose (g/kg) 100 405
Canola oil (g/kg) 70 50
Cellulose (g/kg) 50 50
Wheat starch (g/kg) 404 50
Dextrinized starch (g/kg) 132 0
Cocoa butter (g/kg) 0 50
Hydrogenated vegetable oil (g/kg) 0 131
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Analyser (Beckman Coulter, Fullerton). Serum glucose
and insulin were measured on a Cobas Integra 400
Chemistry Automated Analyser (Roche Diagnostics, Basel,
Switzerland).
RNA extraction and real-time quantitative
PCR (RT-qPCR)
RNA was extracted from tissue homogenates using QIA-
ZOL reagent (Qiagen, Hilden, Germany). After treatment
with deoxyribonuclease 1, cDNA was synthesized from
1 lg RNA, using superscript III reverse transcriptase
(Invitrogen, Mulgrave, Australia). RT-qPCR was per-
formed in a ViiA 7 real-time PCR machine (Invitrogen)
with a Quantifast SYBR Green master mix (Qiagen) and
thermal cycling as follows: 95°C for 5 min then 40 cycles
at 95°C for 10 sec followed by 60°C for 30 sec prior to a
melt curve analysis for validation. Relative mRNA expres-
sion was determined by calibration of Ct values to a stan-
dard curve of dilutions of a pooled mix of cDNA
samples. Expression was then normalized to geometric
mean of three reference genes glyceraldehyde-3-phosphate
dehydrogenase (Gapdh), basic transcription factor-3
(Btf3), and beta-2-microglobulin (B2-mg). Primer
sequences that were used are shown in Table 2.
Western blotting
Serum adiponectin levels were determined by western
blotting. Samples of 1:1000 serum (5 lL) were elec-
trophoresed in 2% Agarose (in Tris-Glycine) gels (Lonza,
Basel, Switzerland) at 70 V for 60 min. Protein levels of
phosphoAKT (pAKT) and sterol regulatory element bind-
ing protein-1 (SREBP-1) were determined using western
blotting of liver tissue extracts. Protein concentration was
quantified using a Pierce BCA Protein Assay Kit (Thermo
Scientific, Rockford). Thirty micrograms of protein from
whole liver protein extracts (pAKT) and 10 lg of protein
from liver nuclear extracts (SREBP-1) were elec-
trophoresed in 10% sodium dodecyl sulfate–10% poly-
acrylamide gels for 10 min at 75 V, then 50 min at
150 V. Samples were then transferred onto polyvinylidene
fluoride (PVDF) membranes (BioRad, Hercules) at 100 V
for 60 min. Membranes were blocked in 5% skim milk
before immunostaining with primary antibodies. Second-
ary antibody binding was performed using horseradish
peroxidase (HRP) antibodies. Visualization was per-
formed using a standard chemiluminescent kit (Supersig-
nal West Femto, Thermo Scientific, Waltham) on a
4000MM pro Image Station (Carestream Health, Inc.,
New York). pAKT and SREBP-1 band net intensity were
normalized to the reference proteins GAPDH and His-
tone-H3, respectively. Primary and secondary antibodies
used for western blots were as follows: adiponectin
(MAB3608, Millipore) 1:10,000, goat anti-mouse HRP
(Invitrogen) 1:200,000; pAKT (sc-7985-R, Santa Cruz)
1:1000, goat anti-rabbit HRP (Invitrogen) 1:200,000;
SREBP-1 (sc-367, Santa Cruz) 1:500, goat anti-rabbit
HRP (Invitrogen) 1:100,000; GAPDH (MAB374, Milli-
pore) 1:150,000, goat anti-mouse HRP (Invitrogen)
1:100,000; histone-H3 (FL-136, sc10809, Santa Cruz)
1:100, goat anti-rabbit HRP (Invitrogen) 1:6000. All sam-
ples were processed concurrently using three gels with a
minimum of three samples per group on each gel.
Statistical analysis
Statistical analysis was performed using GraphPad Prism
6 software (GraphPad, San Diego, CA). For normally dis-
tributed continuous data, groups were compared using
two-way ANOVA based on diet and genotype. For
instances in which a significant interaction existed
between diet and genotype, two predefined post hoc com-
parisons to evaluate the effect of genotype for each diet
Table 2. RT-qPCR primer sequences (50 to 30).
Forward primer Reverse primer
Hamp1 TTGCGATACCAATGCAGAAG GGATGTGGCTCTAGGCTATGTT
Dmt1 CCAGCCAGTAAGTTCAAGGATC GCGTAGCAGCTGATCTGGG
Hephaestin CCGACCTTACACCATTCACC GGACAGAATCATCCGCTTTC
Fas TACCAAGCCAAGCACATTCG TGGCTTCGGCATGAGA
AdipoR2 TACACACAGAGACGGGCAAC TGGCTCCCAAGAAGAACAAG
Ppara CATGTGAAGGCTGTAAGGGCTT TCTTGCAGCTCCGATCACACT
Cpt1 AGACCGTGAGGAACTCAAACCTA TGAAGAGTCGCTCCCACT
Gapdh TCCTGCACCACCAACTGCTTAGC GCCTGCTTCACCACCTTCTTGAT
Btf3 TGGCAGCAAACACCTTCACC AGCTTCAGCCAGTCTCCTTAAAC
B2-mg CTGATACATACGCCTGCAGAGTTAA ATGAATCTTCAGAGCATCATGAT
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were performed using Sidak’s multiple comparisons test.
These comparisons were (1) WT CD versus Hfe+/ CD
and (2) WT HCD versus Hfe+/ HCD. In cases in which
a significant interaction did not occur, P values relating
to overall effect by two-way ANOVA of diet and genotype
are reported. As initial body weight was measured prior
to dietary intervention, an analysis between the two geno-
types (n = 20 per group) was performed using an
unpaired Student’s t-test.
For continuous data that were not normally dis-
tributed, a Kruskal–Wallis test was performed. When the
results of this test were significant (P < 0.05), post hoc
comparisons to evaluate the effect of genotype were per-
formed using Dunn’s multiple comparisons test (group
comparisons as for Sidak’s, above). Data for continuous
variables are represented graphically with box and whisker
plots, demonstrating the maximum, minimum, 25th and
75th centile and median values. Categorical data were
analyzed by Fisher’s exact test and represented in tabular
form.
Results
Weight gain was largely comparable
between genotypes
Weight gain between 8 and 16 weeks of age was largely
comparable between genotypes except for a small increase
in WT HCD-fed mice compared to their Hfe+/ counter-
parts (13.1 g vs 11.0 g, P = 0.04, Sidak’s multiple compar-
ison test after two way ANOVA). This effect may be
related to a higher initial weight at 8 weeks in WT mice.
(28.4 g vs. 26.0 g, P = 0.016). The higher initial weight is
unlikely to be a true genotype effect as a difference was
not seen between the two CD groups. All four groups of
mice (CD and HCD) had been fed only CD up until this
stage. Mean initial weight for all WT mice (n = 20) was
27.5 g, compared to 26.9 g for Hfe+/ mice (n = 20),
P = 0.39, Student’s t-test (Fig. 2A and B).
Diet, but not Hfe genotype influences liver
injury in this model
There was no observed genotype effect on serum ALT
(Fig. 2C). Mice fed HCD of both genotypes developed
steatosis without overt steatohepatitis (Fig. 3). Table 3
shows the histological scoring of liver sections. NAFLD
activity score (NAS) (P = 0.003), steatosis (P < 0.001),
and hepatocyte ballooning (P = 0.038) were associated
with experimental group by Fisher’s exact test. These
associations evidently relate to diet rather than genotype.
No more than minimal fibrosis was seen in any of the
groups (data not shown).
Hepatic iron concentration (HIC) is increased
in Hfe+/ mice in both dietary groups,
consistent with the expected phenotype
Hamp1 is the gene encoding hepcidin, the master regula-
tor of iron homeostasis (Fig. 4A). When Hamp1 is
expressed as a ratio of HIC, expression was found to be
approximately 50% lower in Hfe+/ mice across both
dietary groups (Fig. 4C). This observation is consistent
with haploinsufficiency of the HFE protein in Hfe+/ mice
and supports HFE being the predominant regulator of
Hamp1 expression in this model.
Figure 2. Body weight and serum ALT. (A) Initial body weight (8 weeks). An interaction between diet and genotype was present (P = 0.0044,
two-way ANOVA). Post hoc analysis found increased weight in WT mice fed a HCD compared to Hfe+/ mice (P = 0.016, Sidak’s multiple
comparisons test). No significant changes were seen in CD mice. (B) Weight gain (8–16 weeks). An interaction between diet and genotype was
present (P = 0.040, two-way ANOVA). Post hoc analysis found increased weight gain in WT mice fed a HCD compared to Hfe+/ mice
(P = 0.040, Sidak’s multiple comparisons test). No significant changes were seen in CD mice. (C) Serum alanine aminotransferase (ALT) is not
influenced by diet or genotype. A significant interaction by two-way ANOVA was present (P = 0.047). However, differences between genotype
(Sidak’s multiple comparisons test) were not significant for either mice fed control diet or HCD (n = 9–10 per group).
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High-calorie diet-induced reduction of HIC
occurs independently of hepcidin
HIC was significantly reduced by HCD in both genotypes
(P < 0.0001, two-way ANOVA) (Fig. 4A). The explana-
tion for this is unclear. Hamp1 mRNA expression was
lower in HCD-fed mice (diet effect P = 0.0012, two-way
ANOVA, Fig. 4B). The Hamp1/HIC results demonstrate
that Hamp1 expression when normalized to HIC is unaf-
fected by diet (Fig. 4C). As the hepcidin–ferroportin axis
did not appear to be the cause of the reduced HIC, we
sought to evaluate two further regulators of intestinal iron
absorption, the divalent metal transporter-1 (DMT1) and
hephaestin. There was no significant diet effect at the
mRNA level for either of these by two-way ANOVA
(Fig. 4D and E). Hfe+/ mice demonstrated a reduction
in hephaestin mRNA levels. Given the increased iron
loading in these mice, this response is consistent with
previous work which has shown hephaestin mRNA levels
to be regulated by iron (Anderson et al. 2002).
Hfe+/ mice display impaired glucose
homeostasis
As glucose and insulin are established drivers of hepatic
de novo lipogenesis (Leavens and Birnbaum 2011), we
measured their fasting serum concentrations. Serum glu-
cose was significantly higher in Hfe+/ than WT animals
A B
C D
Figure 3. High-calorie diet leads to increased hepatic steatosis and ballooning degeneration in Hfe+/ mice. Light microscopy of representative
liver sections stained with hematoxylin and eosin are shown (original magnification 9100). (A) WT CD. (B) Hfe+/ CD. (C) WT HCD. (D) Hfe+/
HCD.
Table 3. High-calorie diet, but not heterozygous Hfe gene deletion leads to increased hepatic steatosis, ballooning degeneration, and NAS
score.
Control diet High calorie diet
P-valueWT Hfe+/ WT Hfe+/
NAS (≥2) 0 (0%) 0 (0%) 5 (50%) 5 (50%) 0.003
Steatosis (Yes) 0 (0%) 0 (0%) 8 (80%) 8 (80%) <0.001
Lobular Inflammation (Yes) 4 (40%) 3 (30%) 6 (60%) 6 (60%) 0.54
Ballooning (Yes) 0 (0%) 0 (0%) 4 (40%) 2 (20%) 0.038
Number of mice (%) with NAS (≥2), any macrovesicular steatosis (≥ grade 1), lobular inflammation (≥ grade 1), or ballooning (≥ grade 1). P-
value is the result of Fisher’s exact test. (n = 10 per group).
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(genotype effect P = 0.0007, two-way ANOVA);
8.1 mmol/L versus 7.3 mmol/L in CD-fed mice and
8.0 mmol/L versus 7.2 mmol/L in HCD-fed mice
(Fig. 5A). A trend toward a similar effect was seen for
serum insulin although this did not reach statistical sig-
nificance (Fig. 5B). HOMA-IR score, which is the product
of serum glucose, serum insulin, and a constant, has been
shown to be a useful static measure of insulin resistance
in the fasting state (Matthews et al. 1985). HOMA-IR was
significantly higher in Hfe+/ mice fed both CD
(P = 0.038) and HCD (P= 0.039) using Dunn’s multiple
comparison test after a significant Kruskal–Wallis test
(P = 0.0024) (Fig. 5C). Serum adiponectin has previously
been shown to be regulated by iron in mice and is a
known key determinant of insulin resistance (Gabrielsen
et al. 2012). However, we did not find any significant
effect of genotype on total serum adiponectin (Fig. 5D
and E). Moreover, when we looked specifically at the
active form, high-molecular-weight (HMW) adiponectin,
we again found no genotype effect irrespective of whether
we analyzed absolute HMW adiponectin serum
concentration or HMW adiponectin as a fraction of total
adiponectin.
Despite increased serum glucose and HOMA-
IR score, downstream regulators of de novo
lipogenesis and fatty acid oxidation are
largely unaffected by heterozygous Hfe
deletion
The active form of serine/threonine kinase AKT, phospho
AKT, which is a central regulator of insulin signaling to
lipogenesis pathways, was entirely unaltered by diet or
genotype (Fig. 6A and C). Similarly, nuclear extract quan-
tities of sterol regulatory element binding protein-1
(SREBP-1), the main transcription factor responsible for
regulation of de novo lipogenesis, were also unaffected by
genotype (Fig. 6B and C). HCD, however, was associated
with an increase in nuclear SREBP-1 protein, which may
be substrate driven. mRNA quantities of fatty acid syn-
thase (Fas) and stearoyl CoA desaturase- 1 (Scd1), which
are enzymes involved in hepatic lipogenesis and are
downstream targets of SREBP-1, were also unaffected by
genotype (Fig. 6D and E). Scd1 mRNA, however, was
upregulated by HCD, consistent with the observation that
Scd1 is transcriptionally regulated by SREBP-1 (Mauvoisin
and Mounier 2011). Given the lack of genotype effect on
Figure 4. High-calorie diet-induced reduction in hepatic iron concentration (HIC) occurs independently of hepcidin. (A) Hepatic iron
concentration. HCD was associated with reduced HIC (P < 0.0001, two-way ANOVA). Hfe+/ mice had increased HIC compared to WT mice
(P < 0.0001, two-way ANOVA). (B) Hepatic Hamp1 mRNA expression. Hamp1 was lower in animals fed HCD (P = 0.0012, two-way ANOVA).
Gene effect was not significant (NS). (C) Hepatic Hamp1 mRNA/HIC. Hfe+/ mice had lower Hamp1/HIC ratios (P = 0.0003, two-way ANOVA).
Diet effect was NS. (D) Gut cell Dmt1 mRNA expression. Diet and gene effects were both NS (two-way ANOVA). (E) Gut cell Hephaestin mRNA
expression. Hfe+/ mice had lower Hephaestin expression than WT mice (P = 0.015). Diet effect was NS (two-way ANOVA). (n = 6–10 per
group).
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liver histology or SREBP-1 protein levels and that SREBP-
1 in known to act on Fas and Scd1 by regulation of tran-
scription, we focussed on mRNA rather than protein
levels of these enzymes (Latasa et al. 2003; Mauvoisin and
Mounier 2011). Similarly, there was no effect of Hfe
heterozygosity on mRNA quantities of three key regula-
tors of fatty acid oxidation: adiponectin receptor-2 (Adipo
R2), peroxisome proliferator-activated receptor alpha
(Ppara), and carnitine palmitoyl transferase-1 (Cpt1),
except for a small increase in Cpt1 expression in Hfe+/
mice fed a HCD (P = 0.040, Sidak’s multiple comparisons
test) (Fig. 7A–C).
Discussion
In this study, we have demonstrated that heterozygous
Hfe gene deletion in our mouse model of NAFLD leads
to impaired glucose homeostasis in the fasted state, char-
acterized by raised serum glucose concentrations and
HOMA-IR scores. Despite this, the dysregulation of hep-
atic lipid metabolism and histological evidence of
increased liver injury seen previously in Hfe/ mice were
not seen in Hfe+/ mice.
Increased serum glucose in Hfe+/ mice is a notable
finding and is significant in relation to HFE’s role in
insulin sensitivity, type II diabetes mellitus, and NAFLD
(Nelson et al. 2012; Rong et al. 2012). This study, how-
ever, was not primarily designed to investigate glucose
homeostasis. Undoubtedly, dynamic measures of glucose
homeostasis such as glucose and pyruvate tolerance test-
ing with hyperinsulinemic–euglycemic clamp studies
would help future studies to characterize the extent and
specific location of insulin resistance in this model.
The links between iron, insulin resistance, and type II
diabetes have been extensively studied (Simcox and
McClain 2013). Two large longitudinal cohort studies
have demonstrated increased risk of diabetes associated
with hyperferritinemia (Ford and Cogswell 1999;
Figure 5. Hfe+/ mice have impaired glucose homeostasis irrespective of diet. (A) Serum glucose. Serum glucose was higher in Hfe+/ mice
compared to WT mice (P = 0.0007), diet effect was NS (two-way ANOVA). (B) Serum insulin (mIU/L), presented on logarithmic (base 10) scale.
A difference between groups was present P = 0.004 (Kruskal–Wallis test). Post hoc comparisons by genotype for CD and HCD mice were both
NS (P = 0.057, P = 0.084, respectively, by Dunn’s multiple comparison test). (C) HOMA-IR, presented on logarithmic (base 10) scale. A
difference between groups was present (P = 0.0024) (Kruskal–Wallis test). Hfe+/ was associated with increased HOMA-IR score for mice fed
CD (P = 0.038) and HCD (P = 0.039) (Dunn’s multiple comparison test). Immunoblotting for total serum adiponectin, (D) densitometry, (E)
representative blots. HMW, high-molecular-weight adiponectin. MMW, medium molecular weight adiponectin. Diet and gene effects were
both NS (two-way ANOVA). (n = 9–10 per group).
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Montonen et al. 2012). These associations remained valid
even after accounting for known confounders such as
inflammation. Furthermore, therapeutic phlebotomy as a
method of iron depletion has been shown in small studies
to improve glycemic control in nondiabetic, prediabetic,
and diabetic subjects (Facchini 1998; Fernandez-Real et al.
2002; Houschyar et al. 2012).
Somewhat counterintuitively, previous studies have
suggested enhanced insulin sensitivity in homozygous Hfe
null mice (Huang et al. 2007, 2011). This has been
Figure 6. Hepatic de novo lipogenesis pathways are not upregulated despite hyperglycemia. (A) Immunoblotting densitometry of pAKT (whole
liver protein extracts) normalized to GAPDH. Diet and genotype effects were both NS (two-way ANOVA). (B) Immunoblotting densitometry of
SREBP-1 (nuclear protein extracts) normalized to Histone-H3. HCD was associated with increased nuclear SREBP-1 (P = 0.017). Gene effect was
NS (two-way ANOVA). (C) Representative immunoblots for pAKT, GAPDH, SREBP-1, Histone-H3. (n = 9–10 per group). (D) Hepatic fatty acid
synthase (Fas) mRNA expression. Diet and genotype effects were both NS (two-way ANOVA). (E) Hepatic stearoyl CoA desaturase-1 (Scd1)
mRNA expression. HCD was associated with increased Scd1 expression. Gene effect was NS (two-way ANOVA).
Figure 7. Hepatic lipid metabolism mRNA. (A) Hepatic adiponectin receptor-2 (Adipo R2) mRNA expression. HCD was associated with
increased AdipoR2 expression (P = 0.0039). Gene effect was NS (two-way ANOVA). (B) Hepatic peroxisome proliferator-activated receptor
alpha (Ppara) mRNA expression. Ppara expression was increased by HCD. Gene effect was NS. (C) Hepatic carnitine palmitoyl transferase-1
(Cpt1) mRNA expression. There was a significant interaction between diet and genotype (P = 0.045). Post hoc analysis found increased Cpt1
expression due to Hfe+/ in HCD-fed mice (P = 0.040). In CD-fed mice the results are NS (Sidak’s multiple comparisons test) (n = 10 per
group).
ª 2016 The Authors. Physiological Reports published by Wiley Periodicals, Inc. on behalf of
the American Physiological Society and The Physiological Society.
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proposed to be due to a lack of internalization of adipo-
cyte ferroportin, subsequent adipocyte iron depletion, and
upregulation of the expression of the insulin sensitizing
adipokine, adiponectin (Gabrielsen et al. 2012). This
effect, however, was not seen in our model, as heterozy-
gous Hfe+/ deletion did not appear to be sufficient to
interfere with serum adiponectin levels.
The findings of our study are relevant if one considers
the human data regarding Hfe mutations and type II dia-
betes mellitus risk. A large meta-analysis that reviewed
studies describing Hfe gene polymorphisms and the risk
of type II diabetes concluded that the heterozygous H63D
mutation was associated with increased risk of diabetes
(Rong et al. 2012). In the context of this human data,
our study provides a clear framework and suitable model
for future animal studies exploring the mechanistic links
between HFE and type II diabetes.
Among individuals with NAFLD, the presence of
heterozygous H63D mutation has been associated with
higher steatosis grades and NAS score (Nelson et al.
2012). Given that H63D has less iron loading potential
than the C282Y mutation, this raises the intriguing possi-
bility of an iron-independent role for the HFE protein in
macronutrient metabolism that might protect against dia-
betes and NASH.
Heterozygous Hfe deletion did not appear to influence
liver injury in this model, but it may be possible that his-
tological differences between Hfe+/ and WT mice would
only become evident in older mice with a more pro-
longed exposure to HCD and greater hepatic iron load-
ing. Given the lack of lobular inflammation seen on liver
histology, inflammatory pathways have not been explored
in this model. Although it is possible that such pathways
may be early markers of liver injury, analysis of these
pathways would be better suited to a model with more
prolonged exposure to HCD.
An interesting finding in this study was the effect of
both diet and genotype on hepatic iron concentration
(HIC). Increased hepatic iron in Hfe+/ mice is consistent
with reduced stimulation of hepcidin–ferroportin axis in
the setting of HFE deficiency. Humans with heterozygous
C282Y mutations have been shown to have increased
levels of serum ferritin, a marker of tissue iron stores,
when compared to wild-type controls (Allen et al. 2008).
The lower HIC observed with HCD is consistent with
other previous studies (Tan et al. 2011; Sonnweber et al.
2012). However, the lack of dietary effect on Hamp1
mRNA when normalized to HIC suggests that hepcidin
response remains appropriate in this model. Similarly, we
found no dietary effect on the mRNA levels of two other
regulators of iron absorption, the enterocyte iron trans-
porter DMT1 and the ferroxidase, hephaestin, despite a
previous report of dysregulation of the mRNA transcripts
of these genes in response to a high-fat diet (Sonnweber
et al. 2012).
In conclusion, we have demonstrated impaired glucose
and iron homeostasis with heterozygous Hfe gene deletion
in a mouse model of NAFLD. The genetic defect, how-
ever, was not associated with increased liver injury or
impaired hepatic lipid metabolism.
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